Richard Gonzalez

Richard Gonzalez is the chairman of the board and CEO of pharmaceutical company AbbVie. Originally an executive vice president at Abbott Laboratories, he was asked to lead AbbVie, its spinoff company, when it was launched in 2013. In 2019, AbbVie purchased Allergan for $63 billion.